Skip to main content
CERUS CORP logo

CERUS CORP — Investor Relations & Filings

Ticker · CERS ISIN · US1570851014 LEI · 254900BIEY9XIDA04Q21 US Manufacturing
Filings indexed 1,009 across all filing types
Latest filing 2025-03-11 Director's Dealing
Country US United States of America
Listing US CERS

About CERUS CORP

https://www.cerus.com/

Cerus Corporation is a biomedical products company dedicated to safeguarding the world's blood supply. The company develops and commercializes the INTERCEPT Blood System, a pathogen inactivation technology designed to reduce the risk of transfusion-transmitted infections. The system inactivates a broad spectrum of viruses, bacteria, parasites, and leukocytes in donated blood components. It is used for platelets and plasma, with a system for red blood cells in development. Cerus provides its technology to blood centers and hospitals, aiming to establish a new standard of care for blood safety.

Recent filings

Filing Released Lang Actions
4
Director's Dealing
2025-03-11 English
4
Director's Dealing
2025-03-06 English
4
Director's Dealing
2025-03-06 English
4
Director's Dealing
2025-03-06 English
4
Director's Dealing
2025-03-06 English
4
Director's Dealing
2025-03-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.